15 studies found for:    apatinib
Show Display Options
Rank Status Study
1 Completed A Study of Apatinib in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer
Condition: Non-Small-Cell Lung Cancer
Interventions: Drug: apatinib;   Drug: placebo
2 Completed A Study of Apatinib in Non-triple-negative Metastatic Breast Cancer
Condition: Breast Neoplasms
Intervention: Drug: Apatinib
3 Active, not recruiting Study of Apatinib in Metastatic Triple-Negative Breast Cancer Patients
Condition: Metastatic Breast Cancer
Intervention: Drug: Apatinib
4 Not yet recruiting A Study of Apatinib Versus Docetaxol Patients With Advanced Gastric Cancer
Condition: Gastric Carcinoma
Interventions: Drug: Docetaxel;   Drug: apatinib
5 Completed A Study of Apatinib in Patients With Advanced Hepatocellular Carcinoma
Condition: Advanced Hepatocellular Carcinoma
Intervention: Drug: Apatinib
6 Unknown  Apatinib in the Treatment of Advanced Non-squamous Non-small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Interventions: Drug: apatinib;   Drug: placebo
7 Active, not recruiting Study of Apatinib Tablets in the Treatment of Advanced or Metastatic Gastric Cancer
Condition: Gastric Cancer
Intervention: Drug: Apatinib
8 Unknown  Study of Apatinib as an Inhibitor of Tumor Angiogenesis
Condition: Tumor
Intervention: Drug: apatinib
9 Recruiting Dose-Escalation and Safety Trial of YN968D1
Condition: Cancer Patients With Solid Tumors
Intervention: Drug: YN968D1
10 Completed Apatinib Versus Placebo as a Third Line Treatment in Patients With Advanced or Metastatic Gastric Cancer
Condition: Gastric Carcinoma
Intervention: Drug: apatinib tablet
11 Recruiting Study of Apatinib as 3rd/4th Line Treatment in Patients With Advanced Non-Squamous Non-small Cell Lung Cancer Harboring Wild-type Epidermal Growth Factor Receptor (EGFR)
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Apatinib;   Drug: Placebo
12 Completed Phase III Study of Apatinib Tablets in the Treatment of Advanced or Metastatic Gastric Cancer
Condition: Advanced or Metastatic Gastric Cancer
Interventions: Drug: apatinib;   Drug: placebo
13 Completed Dose Finding and Pharmacokinetics/Pharmacodynamics Study of Apatinib in the Treatment of Advanced Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: Apatinib;   Drug: apatinib
14 Recruiting Study of Apatinib After Systemic Therapy(Chemotherapy and/or Targeted Therapy) in Patients With Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Drug: Apatinib;   Drug: Placebo
15 Unknown  Dose-Escalation and Safety Trial of YN968D1
Condition: Cancer Patients With Solid Tumors
Intervention: Drug: YN968D1

Indicates status has not been verified in more than two years